中国高校科技期刊研究会第9次会员代表大会在北京召开，中宣部出版局副局长张怀海、教育部科学技术与信息化司一级巡视员张国辉等领导出席会议并发表..
英文简介：Hematological Oncology considers for publication articles dealing with experimental and clinical aspects of neoplastic diseases of the hemopoietic and lymphoid systems and relevant related matters. Translational studies applying basic science to clinical issues are particularly welcomed. Manuscripts dealing with the following areas are encouraged:-Clinical practice and management of hematological neoplasia, including: acute and chronic leukemias, malignant lymphomas, myeloproliferative disorders-Diagnostic investigations, including imaging and laboratory assays-Epidemiology, pathology and pathobiology of hematological neoplasia of hematological diseases-Therapeutic issues including Phase 1, 2 or 3 trials as well as allogeneic and autologous stem cell transplantation studies-Aspects of the cell biology, molecular biology, molecular genetics and cytogenetics of normal or diseased hematopoeisis and lymphopoiesis, including stem cells and cytokines and other regulatory systems.Concise, topical review material is welcomed, especially if it makes new concepts and ideas accessible to a wider community. Proposals for review material may be discussed with the Editor-in-Chief. Collections of case material and case reports will be considered only if they have broader scientific or clinical relevance.中文简介：（来自Google、百度翻译）血液肿瘤学考虑发表有关造血和淋巴系统肿瘤疾病的实验和临床方面以及相关问题的文章。将基础科学应用于临床问题的转化研究尤其受到欢迎。鼓励涉及以下领域的手稿:-血液肿瘤的临床实践和管理，包括: 急性和慢性白血病，恶性淋巴瘤，骨髓增生性疾病 -诊断研究，包括影像学和实验室检测 流行病学，血液病血液肿瘤的病理学和病理生物学 -治疗问题，包括1、2或3期试验以及同种异体和自体干细胞移植研究 -正常或患病的造血和淋巴细胞生成的细胞生物学，分子生物学，分子遗传学和细胞遗传学，包括干细胞，细胞因子和其他调节系统。审查材料的建议可以与主编讨论。只有在具有更广泛的科学或临床相关性的情况下，才会考虑收集病例材料和病例报告。
